595 filings
Page 4 of 30
8-K
ix6 dlszfe7gg9j
17 Aug 20
Elite Pharmaceuticals, Inc. Reports Financial Results For The First Quarter Of Fiscal Year 2021
6:09am
8-K/A
jr93a ftwhbmk
31 Jul 20
Financial Statements and Exhibits
5:00pm
EFFECT
2zpxpx6 33k803w3dgcx
28 Jul 20
Notice of effectiveness
12:15am
424B3
pirqhosw1na8ne3
27 Jul 20
Prospectus supplement
5:25pm
CORRESP
s0jgs
23 Jul 20
Correspondence with SEC
12:00am
UPLOAD
jv3okyv7 l6dq92
22 Jul 20
Letter from SEC
12:00am
D
7tbmpf5nu0lbb
13 Jul 20
$26M in equity, sold $500K, 1 investor
12:49pm
8-K
wm02vv 20d3
9 Jul 20
Entry into a Material Definitive Agreement
5:03pm
8-K
kze5skl4s1
29 Jun 20
Provides Conference Call Information
12:00am
8-K
s3wo64maat0npr5cj
24 Jun 20
Amendments to Articles of Incorporation or Bylaws
4:18pm
DEFA14A
1b98g8msy6 vp
11 May 20
Additional proxy soliciting materials
4:49pm
8-K
vrg5qwd
23 Apr 20
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
lhsfqb
26 Feb 20
Entry into a Material Definitive Agreement
4:59pm
8-K
eksmxdmohf1 ro
10 Feb 20
Results of Operations and Financial Condition
5:08pm